Odd-even for 5 days in Delhi from Nov 13

New Delhi, Jun 15: With an increase of 11,502 cases in the past 24 hours, the COVID-19 count in India reached 3,32,424 on Monday, according to the Union Health and Family Welfare Ministry.

The spike is marginally lower than the highest-ever spike of 11,929 new cases the country registered a day earlier.

With 325 deaths being reported from across the country, the toll due to COVID-19 has now reached 9,520.

The COVID-19 count includes 1,53,106 active cases while 1,69,798 patients have been cured and discharged or migrated so far.

Maharashtra with 1,07,958 cases continues to be the worst-affected state in the country with 53,030 active cases while 50,978 patients have been cured and discharged in the state so far. 3,950 deaths have been reported due to the infection so far from Maharashtra.

It is followed by Tamil Nadu with 44,661 cases and the national capital with 41,182 confirmed cases.

New Delhi, Apr 3: The total number of coronavirus cases in Delhi has risen to 384, including 259 who were evacuated from Nizamuddin Markaz, Chief Minister Arvind Kejriwal said on Friday.

In last 24 hours, 91 new cases were reported in the national capital and one more person evacuated from the Markaz died due to coronavirus, taking the total number of deaths in the city to five, he said.

Of the 384 cases, 58 had recent foreign travel history and 38 contracted the virus after coming in contact with them, he added.

Kejriwal said community spread of the virus is not taking place in Delhi yet and there is no need to panic as the situation is under control.

The government has made preparations if the virus starts spreading among people, he said.

The chief minister also launched a WhatsApp helpline - 8800007722 for people to enquire about COVID-19, food banks, shelters among others.

Meanwhile, Kejriwal, deputy chief minister Manish Sisodia and experts will interact with students and answer their queries related to the virus at 3 pm on Saturday.

Washington, May 19: As the scientists across the world are struggling to develop a vaccine for combating coronavirus, US drugmaker Moderna announced on Monday (local time) that the phase I trial of its Covid-19 vaccine has shown positive early results.

The company is hopeful that it's vaccine could be available to the public as early as January next year. Several firms across the world are in the race to develop a vaccine for the deadly virus which has claimed over 3 lakh lives worldwide.

CNN citing Dr. Tal Zaks, Moderna's chief medical officer reported that "if future studies go well, the company's vaccine could be available to the public as early as January".

"This is absolutely good news and news that we think many have been waiting for for quite some time," Zaks was quoted as saying.

Moderna, based in Cambridge, Massachusetts announced that the vaccine developed neutralising antibodies to the virus at levels reaching or exceeding the levels seen in people who have naturally recovered from Covid-19, reported CNN.

These will be followed by phase 2 trials and phase 3 trials, which Moderna plans to start in July.

President Donald Trump had on Friday said that that the United States will be able to deliver a few hundred million doses of COVID-19 vaccine, under 'Operation Warp Speed', by the end of this year.

"I have very recently seen early data from a clinical trial with a coronavirus vaccine and this data made me feel even more confident that we'll be able to deliver a few hundred million doses of vaccine by the end of 2020 and we will do the best we can," Trump had said at a press conference at the White House on Friday.